DJIA 18,153.19 56.29 0.31%
NASDAQ 4,989.33 22.19 0.45%
S&P 500 2,102.03 3.50 0.17%
market minute promo

Celgene (NASDAQ: CELG)

121.06 1.49 (1.25%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CELG $120.96 1.16%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $120.48
Previous Close $119.57
Daily Range $120.34 - $121.76
52-Week Range $66.85 - $125.45
Market Cap $96.9B
P/E Ratio 50.03
Dividend (Yield) $0.00 (0.0%)
Volume 895,465
Average Daily Volume 5,196,626
Current FY EPS $4.32

Sector

Healthcare

Industry

Drug Makers

Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website: http://www.celgene.com/

News & Commentary Rss Feed

3 Big Cap Biotechs That Could Trounce Gilead Sciences This Year

These three companies could post better growth than Gilead Sciences that allow them to be top performers this year.

Credit Suisse: 8 Biotech and Health Care Stocks Add to Your Portfolio Right Now

Jim Cramer's Top Takeaways: Wayfair, Honeywell, Halyard Health, More

Biotech Stock Roundup: Orexigen Soars on Contrave Data, Amgen Scores in Study - Analyst Blog

Celgene's (CELG) Management Presents at Cowen and Company 35th Annual Health Care Conference - Confe

Celgene's (CELG) Management Presents at Cowen and Company 35th Annual Health Care Conference - Conference Call Transcript

3 Drugs Stocks Moving The Industry Upward

Amgen Still In Play With Endeavor To Expand Kyprolis

The 5 Most Loved Biotech Stocks of Portfolio Managers

Celgene's Abraxane Combination Therapy Cleared in the EU - Analyst Blog

Pioneer Fundamental Growth Fund: Why Is It Revving Up?

Amgen: The Best Biotech Stock You Don't Own

See More CELG News...

CELG's Top Competitors

CELG $121.06 (1.25%)
Current stock: CELG
AMGN $160.48 (0.81%)
Current stock: AMGN
GILD $104.25 (1.15%)
Current stock: GILD
$0.00 (0.00%)
Current stock: